nodes	percent_of_prediction	percent_of_DWPC	metapath
Loteprednol—NR3C1—type 2 diabetes mellitus	0.905	1	CbGaD
Loteprednol—NR3C1—Endoderm Differentiation—HHEX—type 2 diabetes mellitus	0.00258	0.031	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—G6PC—type 2 diabetes mellitus	0.0021	0.0252	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA6—type 2 diabetes mellitus	0.00186	0.0223	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—INSR—type 2 diabetes mellitus	0.00185	0.0222	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—PDX1—type 2 diabetes mellitus	0.00178	0.0214	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—HNF1A—type 2 diabetes mellitus	0.00178	0.0214	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—ABCC8—type 2 diabetes mellitus	0.00171	0.0205	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—UCP2—type 2 diabetes mellitus	0.00159	0.0191	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—PHOX2A—type 2 diabetes mellitus	0.00156	0.0187	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—type 2 diabetes mellitus	0.00154	0.0185	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—PCK1—type 2 diabetes mellitus	0.00149	0.0179	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—SLC2A4—type 2 diabetes mellitus	0.00145	0.0175	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—NCOA6—type 2 diabetes mellitus	0.00135	0.0162	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—KCNJ11—type 2 diabetes mellitus	0.00135	0.0162	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALDOB—type 2 diabetes mellitus	0.0013	0.0156	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—PPARGC1A—type 2 diabetes mellitus	0.00125	0.015	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NAMPT—type 2 diabetes mellitus	0.00124	0.0149	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptors—HNF4A—type 2 diabetes mellitus	0.00124	0.0149	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—F7—type 2 diabetes mellitus	0.00118	0.0141	CbGpPWpGaD
Loteprednol—Prednisone—HSD11B1—type 2 diabetes mellitus	0.00113	0.0977	CrCbGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—SLC2A2—type 2 diabetes mellitus	0.00112	0.0135	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—CPT1A—type 2 diabetes mellitus	0.0011	0.0132	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—HNF4A—type 2 diabetes mellitus	0.0011	0.0132	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—GCK—type 2 diabetes mellitus	0.00107	0.0129	CbGpPWpGaD
Loteprednol—NR3C1—Endoderm Differentiation—HNF1B—type 2 diabetes mellitus	0.00103	0.0123	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—NEUROD1—type 2 diabetes mellitus	0.00101	0.0121	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—HNF4A—type 2 diabetes mellitus	0.000979	0.0118	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—IRS2—type 2 diabetes mellitus	0.000977	0.0117	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—LEP—type 2 diabetes mellitus	0.000956	0.0115	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—RETN—type 2 diabetes mellitus	0.000948	0.0114	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—CPT1A—type 2 diabetes mellitus	0.000922	0.0111	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—NAMPT—type 2 diabetes mellitus	0.000904	0.0109	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptors—AR—type 2 diabetes mellitus	0.000859	0.0103	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—F7—type 2 diabetes mellitus	0.000857	0.0103	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—IRS1—type 2 diabetes mellitus	0.000853	0.0102	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—PPARG—type 2 diabetes mellitus	0.000833	0.01	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARGC1A—type 2 diabetes mellitus	0.000827	0.00993	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—KCNQ1—type 2 diabetes mellitus	0.00082	0.00984	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—type 2 diabetes mellitus	0.000816	0.00979	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—SREBF1—type 2 diabetes mellitus	0.000806	0.00968	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—ATF3—type 2 diabetes mellitus	0.000787	0.00945	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—G6PC—type 2 diabetes mellitus	0.000762	0.00915	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—ECE1—type 2 diabetes mellitus	0.000762	0.00915	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—HNF1A—type 2 diabetes mellitus	0.00075	0.009	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—type 2 diabetes mellitus	0.0007	0.00841	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—MIF—type 2 diabetes mellitus	0.000692	0.00831	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—AR—type 2 diabetes mellitus	0.000679	0.00815	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—HNF4A—type 2 diabetes mellitus	0.000676	0.00812	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—type 2 diabetes mellitus	0.000665	0.00798	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—AR—type 2 diabetes mellitus	0.000658	0.0079	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptors—PPARA—type 2 diabetes mellitus	0.000651	0.00782	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—TIMP1—type 2 diabetes mellitus	0.00063	0.00756	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—PCK1—type 2 diabetes mellitus	0.000628	0.00754	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—PPARGC1A—type 2 diabetes mellitus	0.000602	0.00723	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—SIRT1—type 2 diabetes mellitus	0.0006	0.00721	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—AVP—type 2 diabetes mellitus	0.000594	0.00713	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—TCF7L2—type 2 diabetes mellitus	0.000586	0.00704	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—type 2 diabetes mellitus	0.000543	0.00652	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptors—PPARG—type 2 diabetes mellitus	0.000538	0.00646	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—GJA1—type 2 diabetes mellitus	0.000531	0.00638	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—PPARA—type 2 diabetes mellitus	0.000514	0.00618	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—type 2 diabetes mellitus	0.000495	0.00595	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—PPARA—type 2 diabetes mellitus	0.000484	0.00581	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—HIF1A—type 2 diabetes mellitus	0.000471	0.00565	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—type 2 diabetes mellitus	0.000469	0.00563	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—type 2 diabetes mellitus	0.000469	0.00563	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—EDN1—type 2 diabetes mellitus	0.000466	0.00559	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—NAMPT—type 2 diabetes mellitus	0.000454	0.00545	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—TNF—type 2 diabetes mellitus	0.000442	0.00531	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—type 2 diabetes mellitus	0.000432	0.00519	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—type 2 diabetes mellitus	0.00043	0.00517	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—PPARG—type 2 diabetes mellitus	0.000425	0.00511	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—HMGA1—type 2 diabetes mellitus	0.000413	0.00496	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—SREBF1—type 2 diabetes mellitus	0.000405	0.00486	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.0004	0.00481	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—MMP1—type 2 diabetes mellitus	0.000391	0.0047	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.00039	0.00468	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—HIF1A—type 2 diabetes mellitus	0.000388	0.00466	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—AGT—type 2 diabetes mellitus	0.000387	0.00464	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—ADIPOQ—type 2 diabetes mellitus	0.000372	0.00446	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—SERPINE1—type 2 diabetes mellitus	0.000361	0.00433	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—IL6—type 2 diabetes mellitus	0.000357	0.00429	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—SLC2A4—type 2 diabetes mellitus	0.000351	0.00422	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.00035	0.0042	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—MMP1—type 2 diabetes mellitus	0.000345	0.00414	CbGpPWpGaD
Loteprednol—Prednicarbate—NR3C1—type 2 diabetes mellitus	0.000336	0.0292	CrCbGaD
Loteprednol—NR3C1—AP-1 transcription factor network—CCL2—type 2 diabetes mellitus	0.000318	0.00382	CbGpPWpGaD
Loteprednol—Diflorasone—NR3C1—type 2 diabetes mellitus	0.000318	0.0276	CrCbGaD
Loteprednol—Desonide—NR3C1—type 2 diabetes mellitus	0.000318	0.0276	CrCbGaD
Loteprednol—NR3C1—Gene Expression—IGF2BP2—type 2 diabetes mellitus	0.000317	0.00381	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—type 2 diabetes mellitus	0.000314	0.00377	CbGpPWpGaD
Loteprednol—Desoximetasone—NR3C1—type 2 diabetes mellitus	0.00031	0.0269	CrCbGaD
Loteprednol—NR3C1—Adipogenesis—PPARGC1A—type 2 diabetes mellitus	0.000303	0.00363	CbGpPWpGaD
Loteprednol—Fludrocortisone—AR—type 2 diabetes mellitus	0.000302	0.0262	CrCbGaD
Loteprednol—Fluoxymesterone—SHBG—type 2 diabetes mellitus	0.000285	0.0247	CrCbGaD
Loteprednol—Medrysone—NR3C1—type 2 diabetes mellitus	0.000282	0.0244	CrCbGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.00028	0.00336	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—CDKN2A—type 2 diabetes mellitus	0.000278	0.00333	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	0.000277	0.00333	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—LPL—type 2 diabetes mellitus	0.000275	0.00331	CbGpPWpGaD
Loteprednol—Testosterone Propionate—AR—type 2 diabetes mellitus	0.00027	0.0234	CrCbGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—type 2 diabetes mellitus	0.000265	0.00318	CbGpPWpGaD
Loteprednol—Hydrocortamate—NR3C1—type 2 diabetes mellitus	0.000263	0.0228	CrCbGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—SRC—type 2 diabetes mellitus	0.000262	0.00315	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	0.000261	0.00314	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	0.000261	0.00314	CbGpPWpGaD
Loteprednol—Cortisone acetate—NR3C1—type 2 diabetes mellitus	0.000259	0.0224	CrCbGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	0.000258	0.0031	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—FAS—type 2 diabetes mellitus	0.000252	0.00302	CbGpPWpGaD
Loteprednol—Fluoxymesterone—AR—type 2 diabetes mellitus	0.00025	0.0217	CrCbGaD
Loteprednol—NR3C1—Generic Transcription Pathway—NCOA6—type 2 diabetes mellitus	0.000248	0.00298	CbGpPWpGaD
Loteprednol—Budesonide—NR3C1—type 2 diabetes mellitus	0.000244	0.0212	CrCbGaD
Loteprednol—Amcinonide—NR3C1—type 2 diabetes mellitus	0.000244	0.0212	CrCbGaD
Loteprednol—NR3C1—Adipogenesis—PPARA—type 2 diabetes mellitus	0.000243	0.00292	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—HIF1A—type 2 diabetes mellitus	0.000236	0.00284	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—IRS2—type 2 diabetes mellitus	0.000236	0.00283	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—AGT—type 2 diabetes mellitus	0.000236	0.00283	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—RELA—type 2 diabetes mellitus	0.000235	0.00283	CbGpPWpGaD
Loteprednol—Mometasone—NR3C1—type 2 diabetes mellitus	0.000232	0.0202	CrCbGaD
Loteprednol—NR3C1—Adipogenesis—LEP—type 2 diabetes mellitus	0.000231	0.00277	CbGpPWpGaD
Loteprednol—Methyltestosterone—SHBG—type 2 diabetes mellitus	0.00023	0.0199	CrCbGaD
Loteprednol—Rimexolone—NR3C1—type 2 diabetes mellitus	0.00023	0.0199	CrCbGaD
Loteprednol—NR3C1—AP-1 transcription factor network—MMP9—type 2 diabetes mellitus	0.000228	0.00273	CbGpPWpGaD
Loteprednol—Beclomethasone—NR3C1—type 2 diabetes mellitus	0.000217	0.0188	CrCbGaD
Loteprednol—Alclometasone—NR3C1—type 2 diabetes mellitus	0.000211	0.0183	CrCbGaD
Loteprednol—NR3C1—Adipogenesis—IRS1—type 2 diabetes mellitus	0.000206	0.00247	CbGpPWpGaD
Loteprednol—Clobetasol propionate—NR3C1—type 2 diabetes mellitus	0.000205	0.0178	CrCbGaD
Loteprednol—Fludrocortisone—NR3C1—type 2 diabetes mellitus	0.000205	0.0178	CrCbGaD
Loteprednol—Flunisolide—NR3C1—type 2 diabetes mellitus	0.000205	0.0178	CrCbGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.000204	0.00245	CbGpPWpGaD
Loteprednol—Exemestane—CYP3A4—type 2 diabetes mellitus	0.000204	0.0177	CrCbGaD
Loteprednol—Paramethasone—NR3C1—type 2 diabetes mellitus	0.000202	0.0176	CrCbGaD
Loteprednol—Methyltestosterone—AR—type 2 diabetes mellitus	0.000202	0.0175	CrCbGaD
Loteprednol—NR3C1—Adipogenesis—PPARG—type 2 diabetes mellitus	0.000201	0.00242	CbGpPWpGaD
Loteprednol—Ciclesonide—NR3C1—type 2 diabetes mellitus	0.000199	0.0173	CrCbGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—type 2 diabetes mellitus	0.000198	0.00238	CbGpPWpGaD
Loteprednol—Fluorometholone—NR3C1—type 2 diabetes mellitus	0.000198	0.0171	CrCbGaD
Loteprednol—NR3C1—Adipogenesis—INS—type 2 diabetes mellitus	0.000197	0.00237	CbGpPWpGaD
Loteprednol—NR3C1—Endoderm Differentiation—TGFB1—type 2 diabetes mellitus	0.000192	0.00231	CbGpPWpGaD
Loteprednol—Methylprednisolone—NR3C1—type 2 diabetes mellitus	0.000191	0.0166	CrCbGaD
Loteprednol—NR3C1—Adipogenesis—IGF1—type 2 diabetes mellitus	0.000191	0.00229	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—type 2 diabetes mellitus	0.000189	0.00227	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—TGFB1—type 2 diabetes mellitus	0.000188	0.00225	CbGpPWpGaD
Loteprednol—Dexamethasone—CYP11A1—type 2 diabetes mellitus	0.000183	0.0159	CrCbGaD
Loteprednol—NR3C1—Adipogenesis—SERPINE1—type 2 diabetes mellitus	0.000181	0.00218	CbGpPWpGaD
Loteprednol—Clobetasol propionate—CYP1A2—type 2 diabetes mellitus	0.00018	0.0156	CrCbGaD
Loteprednol—Hydrocortisone—SHBG—type 2 diabetes mellitus	0.000173	0.015	CrCbGaD
Loteprednol—Fluoxymesterone—NR3C1—type 2 diabetes mellitus	0.000169	0.0147	CrCbGaD
Loteprednol—NR3C1—Generic Transcription Pathway—HNF4A—type 2 diabetes mellitus	0.000169	0.00203	CbGpPWpGaD
Loteprednol—Triamcinolone—NR3C1—type 2 diabetes mellitus	0.000161	0.014	CrCbGaD
Loteprednol—Hydrocortamate—CYP3A4—type 2 diabetes mellitus	0.000152	0.0132	CrCbGaD
Loteprednol—Dexamethasone—NOS2—type 2 diabetes mellitus	0.000152	0.0132	CrCbGaD
Loteprednol—Cortisone acetate—CYP3A4—type 2 diabetes mellitus	0.00015	0.013	CrCbGaD
Loteprednol—Prednisone—NR3C1—type 2 diabetes mellitus	0.000146	0.0127	CrCbGaD
Loteprednol—NR3C1—Generic Transcription Pathway—CTGF—type 2 diabetes mellitus	0.000145	0.00174	CbGpPWpGaD
Loteprednol—Budesonide—CYP3A4—type 2 diabetes mellitus	0.000142	0.0123	CrCbGaD
Loteprednol—NR3C1—AP-1 transcription factor network—IL6—type 2 diabetes mellitus	0.000141	0.0017	CbGpPWpGaD
Loteprednol—Prednisolone—NR3C1—type 2 diabetes mellitus	0.000135	0.0117	CrCbGaD
Loteprednol—Betamethasone—NR3C1—type 2 diabetes mellitus	0.000132	0.0114	CrCbGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	0.000127	0.00152	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	0.000126	0.00151	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—IL6—type 2 diabetes mellitus	0.000125	0.0015	CbGpPWpGaD
Loteprednol—Alclometasone—CYP3A4—type 2 diabetes mellitus	0.000122	0.0106	CrCbGaD
Loteprednol—NR3C1—Gene Expression—NCOA6—type 2 diabetes mellitus	0.000119	0.00143	CbGpPWpGaD
Loteprednol—Flunisolide—CYP3A4—type 2 diabetes mellitus	0.000119	0.0103	CrCbGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	0.000119	0.00143	CbGpPWpGaD
Loteprednol—Paramethasone—CYP3A4—type 2 diabetes mellitus	0.000117	0.0102	CrCbGaD
Loteprednol—NR3C1—Generic Transcription Pathway—AR—type 2 diabetes mellitus	0.000117	0.00141	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—type 2 diabetes mellitus	0.000116	0.00139	CbGpPWpGaD
Loteprednol—Ciclesonide—CYP3A4—type 2 diabetes mellitus	0.000115	0.01	CrCbGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—AKT1—type 2 diabetes mellitus	0.000115	0.00138	CbGpPWpGaD
Loteprednol—Fluorometholone—CYP3A4—type 2 diabetes mellitus	0.000115	0.00993	CrCbGaD
Loteprednol—NR3C1—Adipogenesis—TGFB1—type 2 diabetes mellitus	0.000114	0.00137	CbGpPWpGaD
Loteprednol—Methylprednisolone—CYP3A4—type 2 diabetes mellitus	0.000111	0.0096	CrCbGaD
Loteprednol—NR3C1—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	0.000108	0.0013	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	0.000108	0.00129	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—TNF—type 2 diabetes mellitus	0.000107	0.00128	CbGpPWpGaD
Loteprednol—Hydrocortisone—NR3C1—type 2 diabetes mellitus	0.000103	0.00893	CrCbGaD
Loteprednol—Dexamethasone—ABCC2—type 2 diabetes mellitus	0.000101	0.00873	CrCbGaD
Loteprednol—Triamcinolone—CYP3A4—type 2 diabetes mellitus	9.34e-05	0.0081	CrCbGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	9.23e-05	0.00111	CbGpPWpGaD
Loteprednol—Triamcinolone—PTGS2—type 2 diabetes mellitus	9.14e-05	0.00793	CrCbGaD
Loteprednol—NR3C1—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	8.88e-05	0.00107	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—IL6—type 2 diabetes mellitus	8.62e-05	0.00103	CbGpPWpGaD
Loteprednol—Prednisone—CYP3A4—type 2 diabetes mellitus	8.47e-05	0.00734	CrCbGaD
Loteprednol—NR3C1—Gene Expression—HNF4A—type 2 diabetes mellitus	8.14e-05	0.000978	CbGpPWpGaD
Loteprednol—Methyltestosterone—CYP3A4—type 2 diabetes mellitus	7.93e-05	0.00687	CrCbGaD
Loteprednol—Prednisolone—CYP3A4—type 2 diabetes mellitus	7.81e-05	0.00677	CrCbGaD
Loteprednol—Dexamethasone—NR3C1—type 2 diabetes mellitus	7.68e-05	0.00666	CrCbGaD
Loteprednol—Betamethasone—CYP3A4—type 2 diabetes mellitus	7.65e-05	0.00663	CrCbGaD
Loteprednol—Betamethasone—PTGS2—type 2 diabetes mellitus	7.49e-05	0.00649	CrCbGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	7.45e-05	0.000895	CbGpPWpGaD
Loteprednol—Prednisone—ALB—type 2 diabetes mellitus	7.39e-05	0.00641	CrCbGaD
Loteprednol—NR3C1—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	7.34e-05	0.000882	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—DNMT1—type 2 diabetes mellitus	7.12e-05	0.000855	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—PSMD6—type 2 diabetes mellitus	7.12e-05	0.000855	CbGpPWpGaD
Loteprednol—Dexamethasone—CYP2E1—type 2 diabetes mellitus	7.07e-05	0.00613	CrCbGaD
Loteprednol—NR3C1—Gene Expression—CTGF—type 2 diabetes mellitus	6.99e-05	0.000839	CbGpPWpGaD
Loteprednol—Methyltestosterone—ALB—type 2 diabetes mellitus	6.92e-05	0.006	CrCbGaD
Loteprednol—NR3C1—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	6.61e-05	0.000794	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—NOTCH2—type 2 diabetes mellitus	6.05e-05	0.000727	CbGpPWpGaD
Loteprednol—Hydrocortisone—CYP3A4—type 2 diabetes mellitus	5.97e-05	0.00518	CrCbGaD
Loteprednol—NR3C1—Gene Expression—AR—type 2 diabetes mellitus	5.64e-05	0.000678	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—CDKN2B—type 2 diabetes mellitus	5.2e-05	0.000625	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—SIRT1—type 2 diabetes mellitus	5.15e-05	0.000618	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—PPP2CA—type 2 diabetes mellitus	4.54e-05	0.000546	CbGpPWpGaD
Loteprednol—Dexamethasone—CYP3A4—type 2 diabetes mellitus	4.45e-05	0.00386	CrCbGaD
Loteprednol—Dexamethasone—PTGS2—type 2 diabetes mellitus	4.36e-05	0.00378	CrCbGaD
Loteprednol—NR3C1—Gene Expression—PPARA—type 2 diabetes mellitus	4.28e-05	0.000514	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—PPARG—type 2 diabetes mellitus	3.54e-05	0.000425	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—SERPINE1—type 2 diabetes mellitus	3.18e-05	0.000382	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—AKT1—type 2 diabetes mellitus	1.4e-05	0.000168	CbGpPWpGaD
